Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
Author:
Affiliation:
1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China
2. Department of Biomedical Engineering, Columbia University, New York 10027, United States
Funder
National Natural Science Foundation of China
Research Fund, Universidade de Macau
Science and Technology Development Fund, Macao Special Administrative Region of the People's Republic of China
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00677
Reference77 articles.
1. Liver cancer: Approaching a personalized care
2. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus
3. Transarterial chemoembolization of hepatocellular carcinoma – agents and drugs: an overview. Part 2
4. Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest
5. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01
2. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance;Journal of Medicinal Chemistry;2024-05-10
3. A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways;Medical Oncology;2024-05-04
4. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy;World Journal of Hepatology;2024-02-27
5. Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution;Journal of Pharmacy and Pharmacology;2024-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3